Evidence map›Paper›PMID 19654214›Full record

ArticleJournal of cell science2009

Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin.

Greg P Coffey, Ranjani Rajapaksa, Raymond Liu, Orr Sharpe, Chiung-Chi Kuo, Sharon Wald Krauss, Yael Sagi, R Eric Davis, Louis M Staudt, Jeff P Sharman and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Review
  3. The molecular mechanism of CD81 antibody inhibition of metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of spleen tyrosine kinase in liver diseases.World journal of gastroenterology · 2020
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. A Novel Human Radixin Peptide Inhibits Hepatitis C Virus Infection at the Level of Cell Entry.International journal of peptide research and therapeutics · 2014
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Greg P CoffeyStanford University, School of Medicine, Division of Oncology, Stanford, CA 94305, USA.
Ranjani Rajapaksa
Raymond Liu
Orr Sharpe
Chiung-Chi Kuo
Sharon Wald Krauss
Yael Sagi
R Eric Davis
Louis M Staudt
Jeff P Sharman
William H Robinson
Shoshana Levy
Stanford University · USNational Cancer Institute · USVA Palo Alto Health Care System · USLawrence Berkeley National Laboratory · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
RNA interference-based screens for molecular targets in cancerZIABC011007 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI STAUDT, LOUIS · 2009 to 2025
$21.0M
RED CELL CYTOSKELETAL PROTEIN 4.1 DURING CELL DIVISIONR01DK059079 · NIDDK · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI KRAUSS, SHARON W · 2000 to 2008
$2.0M
B Cell Lymphomagenesis Induced by Hepatitis C VirusR56AI068100 · NIAID · STANFORD UNIVERSITY · PI LEVY, SHOSHANA · 2006 to 2006
$352k
NIAID NIH HHS AI068100NIAID NIH HHS T32 AI007290NIDDK NIH HHS DK059079
6 · The paper itself

Abstract

CD81 is a tetraspanin family member involved in diverse cellular interactions in the immune and nervous systems and in cell fusion events. However, the mechanism of action of CD81 and of other tetraspanins has not been defined. We reasoned that identifying signaling molecules downstream of CD81 would provide mechanistic clues. We engaged CD81 on the surface of B-lymphocytes and identified the induced tyrosine-phosphorylated proteins by mass spectrometry. This analysis showed that the most prominent tyrosine phosphorylated protein was ezrin, an actin-binding protein and a member of the ezrin-radixin-moesin family. We also found that CD81 engagement induces spleen tyrosine kinase (Syk) and that Syk was involved in tyrosine phosphorylation of ezrin. After engagement of CD81, it colocalized with ezrin and F-actin, and this association was disrupted when Syk activation was blocked. Taken together, these studies suggest a model in which CD81 interfaces between the plasma membrane and the cytoskeleton by activating Syk, mobilizing ezrin, and recruiting F-actin to facilitate cytoskeletal reorganization and cell signaling. This mechanism might explain the pleiotropic effects induced in response to stimulation of cells by anti-CD81 antibodies or by the hepatitis C virus, which uses this molecule as its key receptor.

Indexed as

ActinsAntigens, CDCell LineCytoskeletal ProteinsCytoskeletonEzrinHumansIntracellular Signaling Peptides and ProteinsPhosphorylationProtein TransportProtein-Tyrosine KinasesSyk KinaseTetraspanin 28TyrosineActinsAntigens, CDCD81 protein, humanCytoskeletal ProteinsEzrinIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesSyk KinaseSYK protein, humanTetraspanin 28Tyrosine

Identifiers

PMID19654214
PMCPMC2729262
OpenAlexW828255881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.